Description: The peptide is used to block Anti-ERK1/2 Antibody (#CPA5807) reactivity. Form: Lyophilized powder Gene Symbol: MAPK1; MAPK3 Alternative Names: MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1; MAPK1; ERK2; PRKM1; PRKM2; Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2Entrez Gene (Human): 5595; 5594Entrez Gene (Mouse) : 26417; 26413Entrez Gene (Rat) : 50689; 116590SwissProt (Human): P27361; P28482SwissProt (Mouse) : Q63844; P63085SwissProt (Rat) : P21708; P63086Purity : >85%Directions for Use : Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control : The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability : Shipped at 4°C. Store at -20°C for one year.